Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosisMichael P. Pender, Rajiv Khanna, Leone Beagley et al.|JCI Insight|2018Cited by 160
Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosisMichael P. Pender, Rajiv Khanna, Peter A. Csurhes et al.|JCI Insight|2020Cited by 20
Symptomatic and objective clinical improvement in progressive multiple sclerosis patients treated with autologous Epstein-Barr virus-specific T cell therapy: interim results of a phase I trialMichael P. Pender, Rajiv Khanna, Peter A. Csurhes et al.|Queensland's institutional digital repository (The University of Queensland)|2017Cited by 0